1
|
Shirai N, Yamamoto S, Osawa Y, Tsubaki A, Morishita S, Sugahara T, Narita I. Low muscle strength and physical function contribute to falls in hemodialysis patients, but not muscle mass. Clin Exp Nephrol 2024; 28:67-74. [PMID: 37773244 DOI: 10.1007/s10157-023-02403-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Accepted: 09/03/2023] [Indexed: 10/01/2023]
Abstract
INTRODUCTION Patients on hemodialysis (HD) have a higher incidence of fractures than the general population. Sarcopenia is frequently observed in patients on HD; however, the association of falls with sarcopenia and its diagnostic factors, including muscle mass, muscle strength, and physical function, are incompletely understood. METHODS This prospective cohort study was conducted at a single center. Sarcopenia was assessed according to the 2019 Asian Working Group for Sarcopenia diagnostic criteria. Muscle mass was measured the bioelectrical impedance method. Grip strength was evaluated to assess muscle strength, while the Short Physical Performance Battery (SPPB) was used to assess physical function. Falls and their detailed information were surveyed every other week. RESULTS This study analyzed 65 HD patients (median age, 74.5 [67.5-80.0] years; 33 women [49.2%]). Sarcopenia was diagnosed in 36 (55.4%) patients. During the 1-year observation period, 31 (47.7%) patients experienced accidental falls. The falls group had lower median grip strength than the non-falls group (14.7 [11.4-21.8] kg vs. 22.2 [17.9-27.6] kg; p < 0.001). The median SPPB score was also lower in the falls versus non-falls group (7.0 [5.0-11.0] vs. 11.0 [8.0-12.0]; p = 0.009). In adjusted multiple regression analysis, diagnostic factors, including grip strength (B = 0.96, p = 0.04, R2 = 0.19) and SPPB (B = 1.11, p = 0.006, R2 = 0.23), but not muscle mass, were independently associated with fall frequency. CONCLUSIONS The frequency of falls in HD patients was related to muscle strength and physical function, but not muscle mass.
Collapse
Affiliation(s)
- Nobuyuki Shirai
- Department of Rehabilitation, Niigata Rinko Hospital, Niigata, Japan
| | - Suguru Yamamoto
- Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Niigata, 951-8510, Japan.
| | - Yutaka Osawa
- Internal Medicine, Niigata Rinko Hospital, Niigata, Japan
| | - Atsuhiro Tsubaki
- Institute for Human Movement and Medical Sciences, Niigata University of Health and Welfare, Niigata, Japan
| | - Shinichiro Morishita
- Department of Physical Therapy, School of Health Science, Fukushima Medical University, Fukushima, Japan
| | - Tsubasa Sugahara
- Department of Rehabilitation, Niigata Bandai Hospital, Niigata, Japan
| | - Ichiei Narita
- Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Niigata, 951-8510, Japan
| |
Collapse
|
2
|
Al-Hakeem H, Zhang Z, DeMarco EC, Bitter CC, Hinyard L. Emergency department visits in Parkinson's disease: The impact of comorbid conditions. Am J Emerg Med 2024; 75:7-13. [PMID: 37897921 DOI: 10.1016/j.ajem.2023.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Revised: 10/04/2023] [Accepted: 10/08/2023] [Indexed: 10/30/2023] Open
Abstract
INTRODUCTION Older adults have complex, often overlapping, medical conditions requiring careful management that may lead to increased emergency department usage compared to younger adults. Parkinson's disease (PD), a progressive neurodegenerative disorder characterized by distinct motor and nonmotor features, frequently occurs with additional comorbid disease. Classifying comorbid conditions into clinical subgroups allows for further understanding of the heterogeneity in outcomes in patients with PD. The current study examines the reasons for emergency department (ED) visits in a cohort of patients with PD and identifies comorbidities that are potential risk factors for specific ED presenting conditions. METHODS Using data from Optum's de-identified Integrated Claims-Clinical dataset years 2010-2018, patients with PD were identified based on ICD-9/10 diagnosis codes. We identified all ED visits occurring after the first observed diagnosis code for PD. Comorbid conditions were classified using the AHRQ Clinical Classification Software (CCS). We classified patients using Latent Class Analysis (LCA) and conducted multiple logistic regression models with the outcome of reason-for-visit to examine the associations with comorbidity-profile class, patient demographics, and socio-economic characteristics. RESULTS The most common reasons for ED admission were injuries such as fractures and contusions, diseases of the circulatory system, and general signs and symptoms, including abdominal pain, malaise, and fatigue. Comorbid medical conditions often observed in this patient population include depression, diabetes mellitus, and chronic pulmonary disease. Patients in the "Poorest Health" classification of the LCA had greater odds for ED admission for diseases related to the gastrointestinal system, musculoskeletal system, and injury/poisoning categories and reduced odds for admission for diseases of the circulatory system. DISCUSSION Patients with PD who present to the emergency department with injuries are more likely to be in poor health overall with a high comorbidity burden. Clarifying the complex medical needs of patients with PD is the first step to further individualize care, which may reduce ED visits in this population, improve quality of life, and lessen the footprint on the healthcare system.
Collapse
Affiliation(s)
- Haider Al-Hakeem
- Saint Louis University School of Medicine, 1402 S Grand Blvd, St. Louis, MO 63104, USA.
| | - Zidong Zhang
- Department of Health & Clinical Outcomes Research, 3545 Lafayette Ave, St. Louis, MO 63104, USA; Advanced HEALTH Data (AHEAD) Institute, 3545 Lafayette Ave, St. Louis, MO 63104, USA.
| | - Elisabeth C DeMarco
- Department of Health & Clinical Outcomes Research, 3545 Lafayette Ave, St. Louis, MO 63104, USA; Advanced HEALTH Data (AHEAD) Institute, 3545 Lafayette Ave, St. Louis, MO 63104, USA.
| | - Cindy C Bitter
- Division of Emergency Medicine, Saint Louis University School of Medicine, St. Louis Missouri USA, 1402 S Grand Blvd, St. Louis, MO 63104, USA.
| | - Leslie Hinyard
- Department of Health & Clinical Outcomes Research, 3545 Lafayette Ave, St. Louis, MO 63104, USA; Advanced HEALTH Data (AHEAD) Institute, 3545 Lafayette Ave, St. Louis, MO 63104, USA.
| |
Collapse
|
3
|
Wang H, Li HY, Guo X, Zhou Y. Posture Instability Is Associated with Dopamine Drop of Nigrostriatal System and Hypometabolism of Cerebral Cortex in Parkinson Disease. Curr Neurovasc Res 2021; 18:244-253. [PMID: 34082681 DOI: 10.2174/1567202618666210603124814] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Revised: 02/06/2021] [Accepted: 02/08/2021] [Indexed: 11/22/2022]
Abstract
BACKGROUND Posture instability (PI) is known to be a severe complication in Parkinson's disease (PD), and its mechanism remains poorly understood. Our study aims to explore the changes of brain network in PI of PD, and further investigate the role of peripheral inflammation on activities of different brain regions in PD with PI. METHODS 167 individuals were recruited, including 36 PD cases with PI and 131 ones without PI. We carefully assessed the status of motor and cognitive function, measured serum inflammatory factors, and detected the dopaminergic pathways and the metabolism of different brain regions by positron emission tomography (PET). Data analysis was conducted by variance, univariate analysis, chi-square analysis, logistic regression, and partial correlation. RESULT No difference was found for age or onset age between the two groups (P>0.05). Female patients were susceptible to posture impairment and had a 2.14-fold risk for PI compared with male patients in PD (P<0.05). Patients with PI had more severe impairment of motor and cognitive function for a longer duration than those without PI (P<0.05). The mean uptake ratios of presynaptic vesicular monoamine transporter (VMAT2), which were detected in the caudate nucleus and putamen, were lower in PI group than those without PI (P<0.05). There were lower activities of the midbrain, caudate nucleus, and anterior medial temporal cortex in PI group than those in the non-PI group (P<0.05). Although serum concentrations of immunoglobulins (IgG, IgM, and IgA) and complements (C3, C4) were higher in PI group than those in the non-PI group, only serum IgM concentration had a significant difference between the two groups (P<0.05). We further explored significant inverse correlations of IgG, IgM, IgA, and C4 with activities of some cerebral cortex in PI of PD (P<0.05). CONCLUSION Female patients were susceptible to posture instability and had a 2.14-fold risk for PI of PD. Patients with PI had more severe impairments of motor and cognitive function for a longer duration than those without PI. PI was associated with dopamine drop of the nigrostriatal system and lower activities of the limbic cortex in PD. Peripheral inflammation may be involved in degeneration of the cerebral cortex in PD combined with PI.
Collapse
Affiliation(s)
- Hongyan Wang
- The Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 10053, China
| | - Hong-Yu Li
- School of Pharmacy, Lanzhou University, Lanzhou 730000, China
| | - Xiuhai Guo
- The Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 10053, China
| | - Yongtao Zhou
- The Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing 10053, China
| |
Collapse
|
4
|
Isaacson SH, Dashtipour K, Mehdirad AA, Peltier AC. Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension. Curr Neurol Neurosci Rep 2021; 21:18. [PMID: 33687577 PMCID: PMC7943503 DOI: 10.1007/s11910-021-01104-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/21/2021] [Indexed: 02/07/2023]
Abstract
PURPOSE OF REVIEW In autonomic failure, neurogenic orthostatic hypotension (nOH) and neurogenic supine hypertension (nSH) are interrelated conditions characterized by postural blood pressure (BP) dysregulation. nOH results in a sustained BP drop upon standing, which can lead to symptoms that include lightheadedness, orthostatic dizziness, presyncope, and syncope. nSH is characterized by elevated BP when supine and, although often asymptomatic, may increase long-term cardiovascular and cerebrovascular risk. This article reviews the pathophysiology and clinical characteristics of nOH and nSH, and describes the management of patients with both nOH and nSH. RECENT FINDINGS Pressor medications required to treat the symptoms of nOH also increase the risk of nSH. Because nOH and nSH are hemodynamically opposed, therapies to treat one condition may exacerbate the other. The management of patients with nOH who also have nSH can be challenging and requires an individualized approach to balance the short- and long-term risks associated with these conditions. Approaches to manage neurogenic BP dysregulation include nonpharmacologic approaches and pharmacologic treatments. A stepwise treatment approach is presented to help guide neurologists in managing patients with both nOH and nSH.
Collapse
Affiliation(s)
- Stuart H Isaacson
- Parkinson's Disease and Movement Disorders Center of Boca Raton, 951 NW 13th Street, Bldg. 5-E, Boca Raton, FL, USA.
| | - Khashayar Dashtipour
- Division of Movement Disorders, Department of Neurology, Loma Linda University School of Medicine, Loma Linda, CA, USA
| | - Ali A Mehdirad
- Wright State University, Dayton VA Medical Center, Dayton, OH, USA
| | - Amanda C Peltier
- Department of Neurology and Medicine, Vanderbilt University, Nashville, TN, USA
| |
Collapse
|
5
|
You S, Kim HA, Lee H. Association of Postural Instability with Autonomic Dysfunction in Early Parkinson’s Disease. J Clin Med 2020; 9:jcm9113786. [PMID: 33238599 PMCID: PMC7700469 DOI: 10.3390/jcm9113786] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Revised: 11/14/2020] [Accepted: 11/22/2020] [Indexed: 11/23/2022] Open
Abstract
Background: There have been several pathologic data that support an association between postural instability (PI) and autonomic dysfunction in Parkinson’s disease (PD). The purpose of this study was to investigate the correlation of PI and autonomic deficits in early PD. Methods: We collected 17 patients with a diagnosis of early PD. PI was assessed by computerized dynamic posturography (CDP). Standardized autonomic function test (AFT) and time and frequency domain spectral analysis of heart rate variability (HRV) were performed. CDP data obtained from the 21 patients were compared to that from age- and sex-matched healthy controls. We collected HRV data from 18 other age- and sex-matched controls. All patients were evaluated in the “OFF” state. We used Mann–Whitney U-test to compare parameters of CDP between the early PD and control groups. Spearman correlation was used for correlation analysis between parameters of CDP and autonomic function test in PD patients. Results: Most patients (76.5%) showed mild or moderate autonomic dysfunction in the standardized AFT. In CDP, sensory ratios of equilibrium score (e.g., visual and vestibular) and composite scores were significantly lower in PD patients than in controls. In HRV, the low-frequency/high-frequency ratio during the tilt and the gap of low- frequency/high-frequency ratio from supine to tilt were significantly different in both groups. The parameters of time and frequency domains of HRV reflecting parasympathetic function were correlated with equilibrium scores for somatosensory organization test in CDP. Discussion: PI was associated with parasympathetic autonomic dysfunction in early PD. This result was in accordance with a previous assumption that PI in PD is related to parasympathetic cholinergic neuron loss in the brainstem.
Collapse
Affiliation(s)
| | | | - Hyung Lee
- Correspondence: ; Tel.: +82-53-258-7831
| |
Collapse
|
6
|
Gibson JS, Hunter CB, Hewitt LA. A Call to Action: The Role of Healthcare Providers in Reducing the Burden Associated with Neurogenic Orthostatic Hypotension. Neurol Ther 2020; 9:205-211. [PMID: 32720118 PMCID: PMC7606417 DOI: 10.1007/s40120-020-00203-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Indexed: 01/10/2023] Open
Abstract
Neurogenic orthostatic hypotension (nOH) is a sustained fall in blood pressure upon standing that frequently affects patients with neurodegenerative diseases (e.g., Parkinson disease) and manifests with symptoms such as lightheadedness and dizziness upon standing. nOH can severely affect patients by increasing the risk of falls and injuries and by decreasing functionality, independence, and quality of life. However, the condition is often under-recognized because of many factors, including the nonspecific nature of the symptoms, patient comorbidities, and patients' reluctance to discuss their symptoms with their healthcare providers. Increased awareness of the burden of nOH and recognition of potential barriers to efficient diagnosis may lead to improved clinical outcomes and better quality of life for patients. To better understand the manifestations and real-life impact of living with nOH symptoms, perspectives from a patient with nOH and his caregiver (wife) are provided, along with key findings from a published survey of patients and caregivers on the burden of nOH. In addition, insights and advice on a practical approach for diagnosing, educating, and treating patients with nOH are outlined.
Collapse
Affiliation(s)
- Jessie S Gibson
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA.
| | - Christine B Hunter
- Parkinson's Disease Center and Movement Disorders Center, Baylor College of Medicine, Houston, TX, USA
| | | |
Collapse
|
7
|
Neurogenic Orthostatic Hypotension: An Underrecognized Complication of Parkinson Disease. J Neurosci Nurs 2020; 52:230-233. [PMID: 32649380 DOI: 10.1097/jnn.0000000000000528] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
BACKGROUND Neurogenic orthostatic hypotension (nOH) is a common source of disability but is an often untreated nonmotor symptom of Parkinson disease. The key manifestations of nOH include lightheadedness, dizziness, weakness, and fatigue when standing and engaging in activities in the upright position and result in falls, impaired activities of living, decreased quality of life, and short-term cognitive impairment. Early diagnosis and treatment of nOH are necessary to mitigate its adverse effects and reduce nOH-related symptom burden. CASE STUDY The management of nOH is illustrated through a case study. MANAGEMENT CONSIDERATIONS Alerting providers about the impact and treatment of nOH, accurate measurement of orthostatic blood pressure, and educating patients and caregivers about nonpharmacological treatment options are important strategies to manage nOH. The goal of nOH treatment is to mitigate symptoms and improve the patient's quality of life. CONCLUSIONS Nurses can play a crucial role in the recognition and management of nOH. Nurses who are educated about nOH are well suited to partner with care providers to treat disabling motor and nonmotor symptoms of Parkinson disease.
Collapse
|
8
|
Olshansky B, Muldowney J. Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension. Am J Cardiol 2020; 125:1582-1593. [PMID: 32204870 DOI: 10.1016/j.amjcard.2020.01.037] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Revised: 01/18/2020] [Accepted: 01/22/2020] [Indexed: 12/17/2022]
Abstract
Neurogenic orthostatic hypotension (nOH), a drop in blood pressure upon standing resulting from autonomic malfunction, may cause debilitating symptoms that can affect independence in daily activities and quality-of-life. nOH may also be associated with cardiovascular comorbidities (e.g., supine hypertension, heart failure, diabetes, and arrhythmias), making treatment decisions complicated and requiring management that should be based on a patient's cardiovascular profile. Additionally, drugs used to treat the cardiovascular disorders (e.g., vasodilators, β-blockers) can exacerbate nOH and concomitant symptoms. When orthostatic symptoms are severe and not effectively managed with nonpharmacologic strategies (e.g., water ingestion, abdominal compression), droxidopa or midodrine may be effective. Droxidopa may be less likely than midodrine to exacerbate supine hypertension, based on conclusions of a limited meta-analysis. In conclusion, treating nOH in patients with cardiovascular conditions requires a balance between symptom relief and minimizing adverse outcomes.
Collapse
|
9
|
LeWitt PA, Kymes S, Hauser RA. Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for Falls. Aging Dis 2020; 11:679-691. [PMID: 32489712 PMCID: PMC7220277 DOI: 10.14336/ad.2019.0805] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2019] [Accepted: 08/05/2019] [Indexed: 12/11/2022] Open
Abstract
Parkinson disease (PD) is often associated with postural instability and gait dysfunction that can increase the risk for falls and associated consequences, including injuries, increased burden on healthcare resources, and reduced quality of life. Patients with PD have nearly twice the risk for falls and associated bone fractures compared with their general population counterparts of similar age. Although the cause of falls in patients with PD may be multifactorial, an often under-recognized factor is neurogenic orthostatic hypotension (nOH). nOH is a sustained decrease in blood pressure upon standing whose symptomology can include dizziness/lightheadedness, weakness, fatigue, and syncope. nOH is due to dysfunction of the autonomic nervous system compensatory response to standing and is a consequence of the neurodegenerative processes of PD. The symptoms associated with orthostatic hypotension (OH)/nOH can increase the risk of falls, and healthcare professionals may not be aware of the real-world clinical effect of nOH, the need for routine screening, or the value of early diagnosis of nOH when treating elderly patients with PD. nOH is easily missed and, importantly, healthcare providers may not realize that there are effective treatments for nOH symptoms that could help lessen the fall risk resulting from the condition. This review discusses the burden of, and key risk factors for, falls among patients with PD, with a focus on practical approaches for the recognition, assessment, and successful management of OH/nOH. In addition, insights are provided as to how fall patterns can suggest fall etiology, thereby influencing the choice of intervention.
Collapse
Affiliation(s)
- Peter A LeWitt
- 1Henry Ford Hospital and Wayne State University School of Medicine, West Bloomfield, MI 48322, USA
| | | | - Robert A Hauser
- 3University of South Florida Parkinson's Disease and Movement Disorders Center, Parkinson Foundation Center of Excellence, Tampa, FL 33613, USA
| |
Collapse
|
10
|
Freeman R, Illigens BMW, Lapusca R, Campagnolo M, Abuzinadah AR, Bonyhay I, Sinn DI, Miglis M, White J, Gibbons CH. Symptom Recognition Is Impaired in Patients With Orthostatic Hypotension. Hypertension 2020; 75:1325-1332. [PMID: 32223377 DOI: 10.1161/hypertensionaha.119.13619] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Failure to recognize symptoms of orthostatic hypotension (OH) may result in falls, syncope, and injuries. The relationship between orthostatic changes in blood pressure and symptom occurrence and severity is not known. The goal of the present study was to define the relationship between the occurrence and severity of the symptoms of orthostatic hypotension (OH) and (1) the upright systolic blood pressure (SBP) and (2) the fall in SBP after tilting in patients with OH. We prospectively studied 89 patients with OH. Reported BP values include the lowest BP in the first 3 minutes of tilt and the change in blood pressure during tilt. Subjects were queried about symptoms of orthostatic intolerance while supine and during the first 3 minutes of tilt testing using Question 1 of the Orthostatic Hypotension Questionnaire. Mean tilted SBP was 101.6±26.1 mm Hg and mean SBP fall 47.9±18.1 mm Hg. Mean symptom scores when upright were: light-headedness (2.3/10±2.7), dizziness (1.6/10±2.5), and impending blackout (0.8/10±1.9). The majority of patients were asymptomatic or mildly symptomatic and no discrete cutoff for symptoms was observed. The magnitude of the SBP fall (r=-0.07, P=NS) and the lowest upright SBP (r=0.08, P=NS) did not correlate with any reported symptom. These results suggest a poor relationship between the magnitude of the orthostatic BP fall, the upright orthostatic BP, and symptoms. Many patients are asymptomatic despite substantial SBP falls and low orthostatic blood pressures. These findings have implications for clinical care of patients with OH and clinical trials to treat patients with OH.
Collapse
Affiliation(s)
- Roy Freeman
- From the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (R.F., B.M.W.I., I.B., C.H.G.)
| | - Ben M W Illigens
- From the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (R.F., B.M.W.I., I.B., C.H.G.)
| | - Razvan Lapusca
- Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Germany (R.L.)
| | | | - Ahmad R Abuzinadah
- Department of Internal Medicine, King Abdulaziz University Hospital, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia (A.R.A.)
| | - Istvan Bonyhay
- From the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (R.F., B.M.W.I., I.B., C.H.G.)
| | - Dong-In Sinn
- Department of Neurology, Stanford Medical Center, Palo Alto, CA (D.-I.S., M.M.)
| | - Mitchell Miglis
- Department of Neurology, Stanford Medical Center, Palo Alto, CA (D.-I.S., M.M.)
| | - Jeffrey White
- University of Virginia School of Medicine, Charlottesville (J.W.)
| | - Christopher H Gibbons
- From the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (R.F., B.M.W.I., I.B., C.H.G.)
| |
Collapse
|
11
|
Abstract
Parkinson disease (PD) is associated with a variety of motor and non-motor clinical manifestations, including cardiovascular autonomic dysfunction. Neurogenic orthostatic hypotension (nOH) is a potentially serious manifestation of cardiovascular sympathetic failure that occurs in approximately 30% of patients with PD. Here we review the pathophysiology and effects of the condition as well as treatment considerations for patients with PD and nOH. Screening for nOH using orthostatic symptom questionnaires, orthostatic blood pressure measurements, and specialized autonomic testing is beneficial for the identification of symptomatic and asymptomatic cases because cardiac sympathetic denervation and nOH can occur even at early (premotor) stages of PD. Symptoms of nOH, such as orthostatic lightheadedness, in patients with PD, have been shown to adversely affect patient safety (with increased risk of falls) and quality of life and should prompt treatment with non-pharmacologic and, occasionally, pharmacologic measures. Patients with nOH are also at increased risk of supine hypertension, which requires balancing various management strategies. FUNDING: Lundbeck (Deerfield, IL).
Collapse
Affiliation(s)
| | - Phillip A Low
- Department of Neurology, Mayo Clinic, Rochester, MN, USA
| |
Collapse
|
12
|
Cannom DS. Management of coexistent neurogenic orthostatic hypotension and supine hypertension. J Clin Hypertens (Greenwich) 2019; 21:1732-1734. [PMID: 31599484 DOI: 10.1111/jch.13699] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2019] [Accepted: 08/27/2019] [Indexed: 11/28/2022]
Affiliation(s)
- David S Cannom
- Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| |
Collapse
|
13
|
Fleisher JE, Sweeney MM, Oyler S, Meisel T, Friede N, Di Rocco A, Chodosh J. Disease severity and quality of life in homebound people with advanced Parkinson disease: A pilot study. Neurol Clin Pract 2019; 10:277-286. [PMID: 32983607 DOI: 10.1212/cpj.0000000000000716] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Accepted: 07/17/2019] [Indexed: 11/15/2022]
Abstract
Background As Parkinson disease (PD) progresses, symptoms increase, quality of life (QoL) declines, and individuals may become homebound, often losing access to neurologic care. We aimed to determine whether facilitating expert in-home care could improve our understanding of disease progression, treatment options, and unmet needs in this vulnerable population, and whether such a model could mitigate decline in QoL. Methods Patients with PD meeting Medicare homebound criteria were eligible for quarterly interdisciplinary home visits over 12 months. Each visit entailed an evaluation by a movement disorders neurologist, social worker, and nurse, including history, examination, medication reconciliation, psychosocial evaluation, pharmacologic and nonpharmacologic management, and service referrals. Disease severity, as measured by the Unified Parkinson's Disease Rating Scale (UPDRS), and QoL using the Neuro-QoL were measured at visits 1 and 4. Results Of 27 enrolled patients, 23 completed 4 visits, with high retention and high patient- and caregiver-reported satisfaction. The mean age at baseline was 80.9 years (SD 7.8) with a mean total UPDRS of 65.0 (SD 20.0). After one year of home visits, total UPDRS worsened by a mean of 11.8 points (p < 0.01) without a change in any of 8 QoL domains (p = 0.19-0.95). Conclusions Homebound individuals with advanced PD receiving interdisciplinary home visits experienced no significant decline in QoL over 1 year, despite disease progression. Our findings highlight the disease severity and impaired QoL of the advanced, homebound PD population, and the potential for novel approaches to foster continuity of care.
Collapse
Affiliation(s)
- Jori E Fleisher
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Meghan M Sweeney
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Sarah Oyler
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Talia Meisel
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Naomi Friede
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Alessandro Di Rocco
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Joshua Chodosh
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| |
Collapse
|
14
|
Fleisher JE, Sweeney MM, Oyler S, Meisel T, Friede N, Di Rocco A, Chodosh J. Disease severity and quality of life in homebound people with advanced Parkinson disease: A pilot study. Neurol Clin Pract 2019. [PMID: 32983607 DOI: 10.1212/cpj.0000000000000716 10.1212/cpj.0000000000000716] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Background As Parkinson disease (PD) progresses, symptoms increase, quality of life (QoL) declines, and individuals may become homebound, often losing access to neurologic care. We aimed to determine whether facilitating expert in-home care could improve our understanding of disease progression, treatment options, and unmet needs in this vulnerable population, and whether such a model could mitigate decline in QoL. Methods Patients with PD meeting Medicare homebound criteria were eligible for quarterly interdisciplinary home visits over 12 months. Each visit entailed an evaluation by a movement disorders neurologist, social worker, and nurse, including history, examination, medication reconciliation, psychosocial evaluation, pharmacologic and nonpharmacologic management, and service referrals. Disease severity, as measured by the Unified Parkinson's Disease Rating Scale (UPDRS), and QoL using the Neuro-QoL were measured at visits 1 and 4. Results Of 27 enrolled patients, 23 completed 4 visits, with high retention and high patient- and caregiver-reported satisfaction. The mean age at baseline was 80.9 years (SD 7.8) with a mean total UPDRS of 65.0 (SD 20.0). After one year of home visits, total UPDRS worsened by a mean of 11.8 points (p < 0.01) without a change in any of 8 QoL domains (p = 0.19-0.95). Conclusions Homebound individuals with advanced PD receiving interdisciplinary home visits experienced no significant decline in QoL over 1 year, despite disease progression. Our findings highlight the disease severity and impaired QoL of the advanced, homebound PD population, and the potential for novel approaches to foster continuity of care.
Collapse
Affiliation(s)
- Jori E Fleisher
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Meghan M Sweeney
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Sarah Oyler
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Talia Meisel
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Naomi Friede
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Alessandro Di Rocco
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| | - Joshua Chodosh
- Rush University (JEF), Section of Movement Disorders, Department of Neurological Sciences, Chicago, IL; New York University Langone Health (JEF), Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NY; Kaiser Permanente (MMS), Department of Palliative Care, Lafayette, CO; Intermountain Medical Center (SO), Movement Disorders, Murray, UT; SUNY Downstate Medical Center College of Medicine (TM), Brooklyn, NY; Yale School of Nursing (NF), Orange, CT; Northwell Health and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell (ADR), Long Island, NY; New York University School of Medicine (JC), Division of Geriatric Medicine and Palliative Care, Department of Medicine, New York, NY; and VA New York Harbor Healthcare System (JC), Medicine Service, New York, NY
| |
Collapse
|
15
|
François C, Shibao CA, Biaggioni I, Duhig AM, McLeod K, Ogbonnaya A, Quillen A, Cannon J, Padilla B, Yue B, Orloski L, Kymes SM. Six-Month Use of Droxidopa for Neurogenic Orthostatic Hypotension. Mov Disord Clin Pract 2019; 6:235-242. [PMID: 30949555 PMCID: PMC6417751 DOI: 10.1002/mdc3.12726] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Revised: 11/29/2018] [Accepted: 12/09/2018] [Indexed: 01/09/2023] Open
Abstract
Background Droxidopa is approved for adult patients with symptomatic neurogenic orthostatic hypotension (nOH); there is limited information regarding effects on symptoms, outcomes, and quality of life (QOL) beyond two weeks of treatment. Objective Examine the real‐world experience of patients taking droxidopa after six months of treatment. Methods This non‐interventional, US‐based, prospective cohort study utilized a pharmacy hub, identifying patients who recently started droxidopa for nOH treatment. Questionnaires for fall frequency and other patient‐reported outcomes (PROs) were completed at baseline and one, three, and six months following droxidopa initiation. Results 179 enrolled patients completed baseline surveys. Droxidopa continuation rates were high at months one, three, and six (87%, 79%, and 75%, respectively). From baseline to month one, there was significant reduction in the proportion of patients reporting falling at least once (54.1% vs. 43.0%; P = 0.0039), with similar observations at month three (52.9% vs. 44.5%; P = 0.0588) and month six (51.4% vs. 40.0%; P = 0.0339). Significant improvements from baseline to month one were observed and maintained at months three and six for most PROs, including the Orthostatic Hypotension Symptom Assessment Item 1, Short Falls Efficacy Scale‐International, Sheehan Disability Scale, Physical Component of the 8‐item Short‐Form Health Survey, and Patient Health Questionnaire‐9. Conclusions In this non‐interventional prospective study, fewer nOH patients reported falling after one, three, and six months of droxidopa treatment. Further, improvements reported in nOH symptoms, physical function, and QOL measures were maintained for six months following treatment initiation. Results from randomized clinical trials are required to validate the findings.
Collapse
|
16
|
González‐Salazar C, Takazaki KAG, Martinez ARM, Pimentel‐Silva LR, Jacinto‐Scudeiro LA, Nakagawa ÉY, Fujiwara Murakami CE, Saute JAM, Pedroso JL, Barsottini OGP, Teive HAG, França Jr MC. Autonomic dysfunction in hereditary spastic paraplegia type 4. Eur J Neurol 2019; 26:687-693. [DOI: 10.1111/ene.13878] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2018] [Accepted: 11/19/2018] [Indexed: 02/03/2023]
Affiliation(s)
- C. González‐Salazar
- Department of Neurology School of Medical Sciences University of Campinas (UNICAMP) CampinasBrazil
| | - K. A. G. Takazaki
- Department of Neurology School of Medical Sciences University of Campinas (UNICAMP) CampinasBrazil
| | - A. R. M. Martinez
- Department of Neurology School of Medical Sciences University of Campinas (UNICAMP) CampinasBrazil
| | - L. R. Pimentel‐Silva
- Department of Neurology School of Medical Sciences University of Campinas (UNICAMP) CampinasBrazil
| | - L. A. Jacinto‐Scudeiro
- Medical Genetics and Neurology Services Hospital de Clínicas de Porto Alegre Porto AlegreBrazil
- Department of Internal Medicine and Sciences Universidade Federal do Rio Grande do Sul (UFRGS) Porto AlegreBrazil
| | - É. Y. Nakagawa
- Department of Internal Medicine Neurology Service Universidade Federal do Paraná CuritibaBrazil
| | - C. E. Fujiwara Murakami
- Department of Internal Medicine Neurology Service Universidade Federal do Paraná CuritibaBrazil
| | - J. A. M. Saute
- Medical Genetics and Neurology Services Hospital de Clínicas de Porto Alegre Porto AlegreBrazil
- Department of Internal Medicine and Sciences Universidade Federal do Rio Grande do Sul (UFRGS) Porto AlegreBrazil
| | - J. L. Pedroso
- Department of Neurology Federal University of São Paulo (UNIFESP) São Paulo Brazil
| | - O. G. P. Barsottini
- Department of Neurology Federal University of São Paulo (UNIFESP) São Paulo Brazil
| | - H. A. G. Teive
- Department of Internal Medicine Neurology Service Universidade Federal do Paraná CuritibaBrazil
| | - M. C. França Jr
- Department of Neurology School of Medical Sciences University of Campinas (UNICAMP) CampinasBrazil
| |
Collapse
|
17
|
Fleisher J, Barbosa W, Sweeney MM, Oyler SE, Lemen AC, Fazl A, Ko M, Meisel T, Friede N, Dacpano G, Gilbert RM, Di Rocco A, Chodosh J. Interdisciplinary Home Visits for Individuals with Advanced Parkinson's Disease and Related Disorders. J Am Geriatr Soc 2018; 66:1226-1232. [PMID: 29608779 DOI: 10.1111/jgs.15337] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Parkinson's disease (PD) is a complex, multisymptom, neurodegenerative disease affecting primarily older adults. With progression, many individuals become homebound and removed from coordinated, expert care, resulting in excess morbidity, mortality, and healthcare expenditures in acute care settings and institutions. Home visit care models have achieved the triple aim of improving individual and population health while reducing costs in many frail, community-dwelling geriatric cohorts. This study details a novel, interdisciplinary home visit program specifically designed for individuals with PD and related disorders and their family caregivers built upon best practice principles in the care of multimorbid older adults. At each quarterly home visit, a movement disorders-trained neurologist, social worker, and nurse work in parallel with the individual and caregiver to complete a history, physical, detailed medication reconciliation, psychosocial needs assessment, and home safety assessment. A comprehensive, person-centered plan is agreed upon, referrals to community resources are made, standardized documentation is shared, and follow-up communication is instituted. In the first 2 years, 272 visits were conducted with 85 individuals who represent one of the oldest, most disabled PD populations reported. Satisfaction with and retention in the program were high. This study represents the first translation of the success of interdisciplinary and home-based geriatric care models to a population with a specific neurological disease. Preliminary evidence supports the need for such programs in vulnerable populations. Future studies will prospectively assess person-centered outcomes, the effect of using telemedicine on sustainability, and cost effectiveness.
Collapse
Affiliation(s)
- Jori Fleisher
- Section of Movement Disorders, Department of Neurological Sciences, Rush Medical College, Rush Medical University, Chicago, Illinois.,Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, Department of Neurology, School of Medicine, New York University, New York, New York
| | - William Barbosa
- Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, Department of Neurology, School of Medicine, New York University, New York, New York
| | - Meghan M Sweeney
- Kaiser Permanente, Department of Palliative Care, Lafayette, Colorado
| | - Sarah E Oyler
- Movement Disorders, Intermountain Medical Center, Murray, Utah
| | - Amy C Lemen
- Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, Department of Neurology, School of Medicine, New York University, New York, New York
| | - Arash Fazl
- Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, Department of Neurology, School of Medicine, New York University, New York, New York
| | - Mia Ko
- Albert Einstein Medical Center, Philadelphia, Pennsylvania
| | - Talia Meisel
- Downstate Medical Center College of Medicine, State University of New York, Brooklyn, New York
| | - Naomi Friede
- Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, Department of Neurology, School of Medicine, New York University, New York, New York
| | - Geraldine Dacpano
- Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, Department of Neurology, School of Medicine, New York University, New York, New York
| | - Rebecca M Gilbert
- Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, Department of Neurology, School of Medicine, New York University, New York, New York
| | - Alessandro Di Rocco
- Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health, Department of Neurology, School of Medicine, New York University, New York, New York
| | - Joshua Chodosh
- Division of Geriatric Medicine and Palliative Care, Department of Medicine, School of Medicine, New York University, New York, New York.,Medicine Service, Veterans Affairs New York Harbor Healthcare System, New York, New York
| |
Collapse
|
18
|
Amara AW, Memon AA. Effects of Exercise on Non-motor Symptoms in Parkinson's Disease. Clin Ther 2018; 40:8-15. [PMID: 29198450 PMCID: PMC5875718 DOI: 10.1016/j.clinthera.2017.11.004] [Citation(s) in RCA: 54] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2017] [Revised: 11/09/2017] [Accepted: 11/10/2017] [Indexed: 02/07/2023]
Abstract
Patients with Parkinson's disease experience disabling non-motor symptoms, including autonomic dysfunction, cognitive decline, and sleep disorders. Pharmacologic treatments for these symptoms are often ineffective or have intolerable side effects. Therefore, non-pharmacologic interventions are an attractive alternative. Exercise in particular has the potential to alleviate the progressive impairment related to these non-motor symptoms. In this commentary, we explore available research that addresses the impact of exercise and physical activity on autonomic dysfunction, cognitive impairment, and sleep disorders in Parkinson's disease and suggest areas in need of further study. Many gaps remain in our understanding of the most effective exercise intervention for these symptoms, the mechanisms underlying exercise-induced changes, and the best way to monitor response to therapy. However, available research suggests that exercise is a promising approach to improve non-motor symptoms in patients with Parkinson's disease.
Collapse
Affiliation(s)
- Amy W Amara
- Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.
| | - Adeel A Memon
- Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama
| |
Collapse
|
19
|
Abstract
Cardiovascular autonomic dysfunctions, including neurogenic orthostatic hypotension, supine hypertension and post-prandial hypotension, are relatively common in patients with Parkinson disease. Recent evidence suggests that early autonomic impairment such as cardiac autonomic denervation and even neurogenic orthostatic hypotension occur prior to the appearance of the typical motor deficits associated with the disease. When neurogenic orthostatic hypotension develops, patients with Parkinson disease have an increased risk of mortality, falls, and trauma-related to falls. Neurogenic orthostatic hypotension reduces quality of life and contributes to cognitive decline and physical deconditioning. The co-existence of supine hypertension complicates the treatment of neurogenic orthostatic hypotension because it involves the use of drugs with opposing effects. Furthermore, treatment of neurogenic orthostatic hypotension is challenging because of few therapeutic options; in the past 20 years, the US Food and Drug Administration approved only two drugs for the treatment of this condition. Small, open-label or randomized studies using acute doses of different pharmacologic probes suggest benefit of other drugs as well, which could be used in individual patients under close monitoring. This review describes the pathophysiology of neurogenic orthostatic hypotension and supine hypertension in Parkinson disease. We discuss the mode of action and therapeutic efficacy of different pharmacologic agents used in the treatment of patients with cardiovascular autonomic failure.
Collapse
Affiliation(s)
- Cyndya A. Shibao
- Department of Medicine, Division of Clinical Pharmacology, Vanderbilt Autonomic Dysfunction Center, Vanderbilt University Medical Center, Nashville, TN
| | - Horacio Kaufmann
- Department of Neurology, NYU Langone Medical Center, Dysautonomia Center, 530 1st Avenue, New York, NY, USA.
| |
Collapse
|